Literature DB >> 19034318

Metabolic syndrome pathophysiology: the role of adipose tissue.

Jose M Ordovas1, Dolores Corella.   

Abstract

The metabolic syndrome comprises a set of metabolic and physiological risk factors associated with elevated cardiovascular disease risk. The expression of each one of its major factors (hypertriglyceridemia, low high-density lipoprotein cholesterol levels, hypertension, abdominal obesity, and insulin resistance) has been found to be the result of complex interactions between genetic and environmental factors. Moreover, one of them, obesity, may play a major role in triggering the metabolic syndrome by interacting with genetic variants at candidate genes for dyslipidemia, hypertension, and insulin resistance. In support of this hypothesis, several studies at several candidate genes, mainly adipokines and perilipin, have already demonstrated the significance of these interactions; however, the information and its solidity are still very limited and in many cases, replication studies are still lacking in the literature. Therefore, more studies with better epidemiological design and standardized adiposity measures are needed to estimate the contribution of body weight and fat distribution to the genetic predisposition to the metabolic syndrome, the most common CVD risk factor in industrialized societies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034318      PMCID: PMC4426988          DOI: 10.1038/ki.2008.517

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  30 in total

1.  Polymorphisms in PLIN and hypertension combined with obesity and lipid profiles in Han Chinese.

Authors:  Weili Yan; Shufeng Chen; Jianfeng Huang; Yan Shen; Boqin Qiang; Dongfeng Gu
Journal:  Obes Res       Date:  2004-11

Review 2.  Role of PAT proteins in lipid metabolism.

Authors:  C Londos; C Sztalryd; J T Tansey; A R Kimmel
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

Review 3.  Adipokines: the missing link between insulin resistance and obesity.

Authors:  B Antuna-Puente; B Feve; S Fellahi; J-P Bastard
Journal:  Diabetes Metab       Date:  2008-02       Impact factor: 6.041

Review 4.  Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine.

Authors:  Maral Ouzounian; Douglas S Lee; Anthony O Gramolini; Andrew Emili; Masahiro Fukuoka; Peter P Liu
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223

Review 5.  The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences.

Authors:  Sarah de Ferranti; Dariush Mozaffarian
Journal:  Clin Chem       Date:  2008-04-24       Impact factor: 8.327

Review 6.  Family study designs in the age of genome-wide association studies: experience from the Framingham Heart Study.

Authors:  L Adrienne Cupples
Journal:  Curr Opin Lipidol       Date:  2008-04       Impact factor: 4.776

Review 7.  Why study gene-environment interactions?

Authors:  Jose M Ordovas; E Shyong Tai
Journal:  Curr Opin Lipidol       Date:  2008-04       Impact factor: 4.776

8.  Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity.

Authors:  J T Tansey; C Sztalryd; J Gruia-Gray; D L Roush; J V Zee; O Gavrilova; M L Reitman; C X Deng; C Li; A R Kimmel; C Londos
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

9.  Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.

Authors:  John K Ninomiya; Gilbert L'Italien; Michael H Criqui; Joanna L Whyte; Anthony Gamst; Roland S Chen
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

10.  Study of the impact of perilipin polymorphisms in a French population.

Authors:  Aline Meirhaeghe; Séverine Thomas; Frédéric Ancot; Dominique Cottel; Dominique Arveiler; Jean Ferrières; Philippe Amouyel
Journal:  J Negat Results Biomed       Date:  2006-07-12
View more
  7 in total

Review 1.  Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Authors:  Song-Yang Zhang; Ming-Jiang Xu; Xian Wang
Journal:  Br J Pharmacol       Date:  2017-05-16       Impact factor: 8.739

2.  Transition of Metabolic Phenotypes and Risk of Atrial Fibrillation According to BMI: Kailuan Study.

Authors:  Maoxiang Zhao; Wenjuan Du; Qianqian Zhao; Yating Chen; Bin Li; Zhonghui Xie; Zihao Fu; Nan Zhang; Xiaowei Cheng; Xiaoqian Li; Siyu Yao; Miao Wang; Chi Wang; Shouling Wu; Hao Xue; Yang Li
Journal:  Front Cardiovasc Med       Date:  2022-06-28

Review 3.  An overview of the genomics of metabolic syndrome.

Authors:  Jacquelyn Y Taylor; Aldi T Kraja; Lisa de Las Fuentes; Ansley Grimes Stanfill; Ashley Clark; Ann Cashion
Journal:  J Nurs Scholarsh       Date:  2013-01-31       Impact factor: 3.176

4.  A Critical Examination of the Use of Trained Health Coaches to Decrease the Metabolic Syndrome for Participants of a Community-Based Diabetes Prevention and Management Program.

Authors:  Brandon Lucke-Wold; Samantha Shawley; John Spencer Ingels; Jonathan Stewart; Ranjita Misra
Journal:  J Healthc Commun       Date:  2016-11-01

5.  U-shaped association between low-density lipid cholesterol and diabetes mellitus in patients with hypertension.

Authors:  Lin Liu; Geng Shen; Jia-Yi Huang; Yu-Ling Yu; Chao-Lei Chen; Yu-Qing Huang; Ying-Qing Feng
Journal:  Lipids Health Dis       Date:  2019-08-17       Impact factor: 3.876

Review 6.  Phytosterols: Nutritional Health Players in the Management of Obesity and Its Related Disorders.

Authors:  Teresa Vezza; Francisco Canet; Aranzazu M de Marañón; Celia Bañuls; Milagros Rocha; Víctor Manuel Víctor
Journal:  Antioxidants (Basel)       Date:  2020-12-12

7.  SMRT Regulates Metabolic Homeostasis and Adipose Tissue Macrophage Phenotypes in Tandem.

Authors:  Jonathan H Kahn; Anna Goddi; Aishwarya Sharma; Joshua Heiman; Alanis Carmona; Yan Li; Alexandria Hoffman; Kelly Schoenfelt; Honggang Ye; Alexandria M Bobe; Lev Becker; Anthony N Hollenberg; Ronald N Cohen
Journal:  Endocrinology       Date:  2020-10-01       Impact factor: 4.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.